doi:10.3969/j.issn.1673-8640.2015.07.015

Abstract

CLC Number:

R446.62

Figures/Tables 1

References 13

[1]	王江滨. 病毒性肝炎的肝外自身免疫现象[J].肝脏,2004,9(4):270-271.
[2]	魏方,张鹏,范德胜.慢性病毒性肝炎患者抗核抗体检测的临床意义[J].实验与检验医学,2013,31(4):364-366.
[3]	中华医学会传染病与寄生虫病学分会,中华医学会肝病学分会.病毒性肝炎防治方案[J].中华传染病杂志,2001,19(1):56-62.
[4]	林晓梅,潘钦石,张文辉,等.慢性乙型肝炎患者产生自身免疫的研究[J].中华医院感染学杂志,2009,19(8):889-891.
[5]	范琪,包金,姚迪,等.丙型肝炎病毒感染者血清自身抗体检测及临床意义研究[J].现代预防医学,2014,41(2):311-313.
[6]	王妙婵,徐爱芳,刘苑.慢性乙肝进展过程中自身抗体检测的临床意义[J].中国卫生检验杂志,2015,25(6):852-853.
[7]	张悦,朱玉琨,王惠萱,等.慢性丙型肝炎患者自身抗体检测的临床分析[J].西南国防医药,2004,14(2):166-167.
[8]	PAWLOTSKY JM,BEN YAHIA M,ANDRE C,et al.Immunological disorders in C virus chronic active hepatitis: a prospective case-control study[J].Hepatology,1994,19(4):841-848.
[9]	林华,林亦可,林丽容.莆田地区慢性丙型肝炎患者血清自身抗体的检测及意义[J].海峡预防医学杂志,2011,17(5):72-73.
[10]	邹莉. 乙型肝炎病毒感染者血清抗核抗体的研究[J].检验医学与临床,2013,10(10):1217-1218.
[11]	马丽娜,黄云丽,张永宏,等.慢性丙型肝炎患者自身抗体检测及意义(附82例慢性丙型肝炎病例分析)[J].中华现代内科学杂志,2004,1(3):226-228.
[12]	孙萍,唐志琴,穆红.225例肝病患者自身抗体检测结果分析[J].实用检验医师杂志,2014,6(2):98-101.
[13]	张利方,李方,石莉萍,等.自身免疫性肝炎和乙型肝炎患者自身抗体检测及对比分析[J].微循环学杂志,2010,20(1):40-41.

组别	例数	AMA	AMA-M2	SMA	LC-1	LKM	SLA/LP	ANA	合计
甲型肝炎	56	1(1.79)	0(0)	0(0)	0(0)	0(0)	0(0)	4	5(8.93)
乙型肝炎	157	9(5.73)	6(3.82)	2(1.27)	0(0)	1(0.64)	0(0)	24(15.29)	42(26.75)
丙型肝炎	115	16(13.91)	8(6.96)	1(0.87)	2(1.74)	6(5.22)	0(0)	39(33.91)	72(62.61)
丁型肝炎	23	0(0)	0(0)	0(0)	0(0)	0(0)	0(0)	1(4.35)	1(4.35)
戊型肝炎	19	0(0)	0(0)	0(0)	0(0)	0(0)	0(0)	0(0)	0(0)
χ²值		14.28	7.03	1.22	4.46	10.07	-	31.51	81.61
P值		0.01	0.13	0.87	0.35	0.04	-	0.00	0.00
总计	370	26(7.03)	14(3.78)	3(0.81)	2(0.54)	7(1.89)	0(0)	68(18.38)	120(32.43)

组别	例数	AMA	AMA-M2	SMA	LC-1	LKM	SLA/LP	ANA	合计
甲型肝炎	56	1(1.79)	0(0)	0(0)	0(0)	0(0)	0(0)	4	5(8.93)
乙型肝炎	157	9(5.73)	6(3.82)	2(1.27)	0(0)	1(0.64)	0(0)	24(15.29)	42(26.75)
丙型肝炎	115	16(13.91)	8(6.96)	1(0.87)	2(1.74)	6(5.22)	0(0)	39(33.91)	72(62.61)
丁型肝炎	23	0(0)	0(0)	0(0)	0(0)	0(0)	0(0)	1(4.35)	1(4.35)
戊型肝炎	19	0(0)	0(0)	0(0)	0(0)	0(0)	0(0)	0(0)	0(0)
χ²值		14.28	7.03	1.22	4.46	10.07	-	31.51	81.61
P值		0.01	0.13	0.87	0.35	0.04	-	0.00	0.00
总计	370	26(7.03)	14(3.78)	3(0.81)	2(0.54)	7(1.89)	0(0)	68(18.38)	120(32.43)

[1]	TANG Qingqin, QIAO Longwei, YIN Jingping, ZHANG Sheng, FENG Bin, LIANG Yuting. Correlation of peripheral blood monocyte count and serum anti-phospholipase A2 receptor antibody in patients with nephrotic syndrome [J]. Laboratory Medicine, 2023, 38(7): 647-652.
[2]	WANG Haiping, LI He. BISAP score combined with serum sRAGE for predicting hyperlipidemic acute pancreatitis severity and short-term prognosis [J]. Laboratory Medicine, 2023, 38(7): 653-658.
[3]	WU Jie, LI Zenghe, CHEN Baorong, KONG Xujing. Establishment of traceable steroid hormone standard curve for dried blood spot samples [J]. Laboratory Medicine, 2023, 38(5): 489-493.
[4]	. [J]. Laboratory Medicine, 2023, 38(3): 291-293.
[5]	. [J]. Laboratory Medicine, 2023, 38(1): 100-102.
[6]	. [J]. Laboratory Medicine, 2022, 37(9): 892-893.
[7]	SUN Xiaodan, LIU Yiwen, HE Yiqing, DU Yan, ZHANG Guoliang, GAO Feng, YANG Cuixia. Research progress on the role of estrogen receptor in osteosarcoma [J]. Laboratory Medicine, 2022, 37(4): 313-318.
[8]	SUN Xiaodan, XU Jing, LIU Yiwen, HE Yiqing, DU Yan, ZHANG Guoliang, GAO Feng, YANG Cuixia. Inhibitory effects of antiestrogen on the proliferation and CCL2 expression of osteosarcoma cells [J]. Laboratory Medicine, 2022, 37(4): 319-324.
[9]	CHEN Si, LIU Hua, LIU Yiwen, HE Yiqing, ZHANG Guoliang, YANG Cuixia, DU Yan, GAO Feng. Clinical significance of combined determination of serum HER-2 and CD44 in colorectal cancer [J]. Laboratory Medicine, 2022, 37(4): 336-341.
[10]	ZHAO Mingna, ZHANG Chenzi, HONG Qiushuang, LOU Jiatao. Mechanism of IL-8/miR-182 positive feedback regulatory axis in non-small cell lung cancer [J]. Laboratory Medicine, 2022, 37(4): 349-355.
[11]	ZHANG Zhibin, YANG Wanyong, RUAN Fuwang, WEN Qinghui. Roles of total IgE,sIgE and 25（OH）D in the evaluation of infant atopic dermatitis [J]. Laboratory Medicine, 2022, 37(3): 217-220.
[12]	. [J]. Laboratory Medicine, 2021, 36(12): 1264-1266.
[13]	QIU Fang, ZHU Ping, JIANG Peng, WANG Chan. Relation between anti-gp210 antibody,anti-sp100 antibody and ALBI score in patients with primary biliary cholangitis [J]. Laboratory Medicine, 2021, 36(11): 1106-1109.
[14]	. [J]. Laboratory Medicine, 2021, 36(9): 925-928.
[15]	LIU Yang, ZHANG Zhiping, PENG Daorong, SONG Liuwei, GE Shengxiang, HAO Xiaoke, LIU Jiayun. Establishment and performance evaluation of chemiluminescent microparticle immunoassay for the determination of high concentration HbsAg [J]. Laboratory Medicine, 2020, 35(10): 1056-1061.

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 1

References 13

Related Articles 15

Recommended Articles

Metrics